Clinical Trial Update: Effect of Indomethacin on the Progression of Alzheimer's Disease [Phase 3]

View source ↗

Summary

This update covers a completed Phase 3 trial evaluating whether indomethacin can modify the progression of Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED